CIK: 0001694297
Total reported value
$145.9M
Reporting period: 2026-03-31 · Number of holdings: 16
22NW, LP disclosed 16 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $145.9M and a quarterly turnover rate of 78.5%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "0-9"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add NKTR
-15.1% $6.2M
Add NSP
+411.9% $9.6M
Add FSTR
-10.4% -$2.3M
Add LFCR
0.0% -$4.2M
Add SRI
+12.5% -$780.6K
Add MLYS
+24.0% -$966.9K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | FSTR | Foster (lb) Co-a | Stock-Other | 20.41% | +6.90% | -10.40% | |
| 2 | NKTR | Nektar Therapeutics | Stock-Other | 13.86% | +7.97% | -15.10% | |
| 3 | LFCR | Lifecore Biomedical INC | Stock-Other | 12.93% | +3.24% | — | |
| 4 | NSP | Insperity INC | Stock-Other | 9.14% | +7.57% | +411.94% | |
| 5 | MLYS | Mineralys Therapeutics INC | Stock-Other | 8.25% | +2.78% | +24.00% | |
| 6 | SRI | Stoneridge INC | Stock-Other | 8.17% | +2.83% | +12.51% | |
| 7 | FOXF | Fox Factory Holding CORP | Stock-Other | 7.65% | +7.65% | NEW | |
| 8 | CULP | Culp INC | Stock-Other | 3.49% | +0.70% | — | |
| 9 | CMT | Core Molding Technologies In | Stock-Other | 3.42% | +1.54% | — | |
| 10 | RGNX | Regenxbio INC | Stock-Other | 2.83% | -2.77% | -46.65% | |
| 11 | UFI | Unifi INC | Stock-Other | 2.09% | +0.83% | — | |
| 12 | TISI | Team INC | Stock-Other | 1.86% | +0.85% | — | |
| 13 | RZLT | Rezolute INC | Stock-Other | 1.72% | +0.90% | — | |
| 14 | FB1 | Farmer Bros Co | Stock-Other | 1.70% | +0.50% | — | |
| 15 | ELDN | Eledon Pharmaceuticals INC | Stock-Other | 1.34% | +0.94% | — | |
| 16 | PFX | Phenixfin CORP | Stock-Other | 1.15% | -1.04% | -63.43% |
Performance for Q3 2026
+18.1%
Performance Last 4 Quarters
+17.5%
Based on 74% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 16 | $145.9M | 79 | |
| 2025-12-31 | 20 | $237.6M | 42 | |
| 2025-09-30 | 21 | $212.3M | 73 | |
| 2025-06-30 | 21 | $158.8M | 0 | |
| 2025-03-31 | 20 | $149.1M | 100 | |
| 2024-12-31 | 16 | $158.5M | 0 | |
| 2024-09-30 | 13 | $119.3M | 0 | |
| 2024-06-30 | 13 | $117.2M | 0 | |
| 2024-03-31 | 13 | $116.1M | 0 | |
| 2023-12-31 | 14 | $153.5M | 0 | |
| 2023-09-30 | 14 | $140.3M | 0 | |
| 2023-06-30 | 14 | $160.1M | 0 | |
| 2023-03-31 | 17 | $162.7M | 0 | |
| 2022-12-31 | 19 | $185.2M | 0 | |
| 2022-09-30 | 20 | $176.8M | 0 | |
| 2022-06-30 | 20 | $188.4M | 0 | |
| 2022-03-31 | 25 | $275.4M | 0 | |
| 2021-12-31 | 25 | $323.4M | 0 | |
| 2021-09-30 | 28 | $335.7M | 0 | |
| 2021-06-30 | 34 | $372.1M | 50 | |
| 2021-03-31 | 36 | $324.6M | 41 | |
| 2020-12-31 | 35 | $279.3M | 43 | |
| 2020-09-30 | 39 | $197.2M | 69 | |
| 2020-06-30 | 63 | $184.4M | 79 | |
| 2020-03-31 | 111 | $128.6M | 99 | |
| 2019-12-31 | 28 | $88.1M | 44 | |
| 2019-09-30 | 24 | $75.8M | 54 | |
| 2019-06-30 | 30 | $92.3M | 59 | |
| 2019-03-31 | 41 | $143.6M | 55 | |
| 2018-12-31 | 60 | $160.4M | 63 | |
| 2018-09-30 | 46 | $186.5M | 39 | |
| 2018-06-30 | 45 | $192.5M | 46 | |
| 2018-03-31 | 56 | $192.0M | 38 | |
| 2017-12-31 | 65 | $203.2M | 45 | |
| 2017-09-30 | 85 | $171.3M | 35 | |
| 2017-06-30 | 83 | $177.0M | 23 | |
| 2017-03-31 | 93 | $172.9M | 40 | |
| 2016-12-31 | 104 | $166.8M | 0 |
22nw, LP's most significant position changes for 2026-03-31: Sold out: Anebulo Pharmaceuticals INC (ANEB); New buy: Fox Factory Holding CORP (FOXF); Sold out: Mayville Engineering Co INC (MEC); Sold out: MeiraGTx Holdings plc (MGTX); Sold out: Strata Skin Sciences INC (SSKN).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NKTR | Nektar Therapeutics | +8% | -15.10% | Trim |
| 2 | NSP | Insperity INC | +7.6% | +411.94% | Add |
| 3 | FSTR | Foster (lb) Co-a | +6.9% | -10.40% | Trim |
| 4 | LFCR | Lifecore Biomedical INC | +3.2% | — | Unchanged |
| 5 | SRI | Stoneridge INC | +2.8% | +12.51% | Add |
| 6 | MLYS | Mineralys Therapeutics INC | +2.8% | +24.00% | Add |
| 7 | CMT | Core Molding Technologies In | +1.5% | — | Unchanged |
| 8 | ELDN | Eledon Pharmaceuticals INC | +0.9% | — | Unchanged |
| 9 | RZLT | Rezolute INC | +0.9% | — | Unchanged |
| 10 | TISI | Team INC | +0.9% | — | Unchanged |
| 11 | UFI | Unifi INC | +0.8% | — | Unchanged |
| 12 | CULP | Culp INC | +0.7% | — | Unchanged |
| 13 | FB1 | Farmer Bros Co | +0.5% | — | Unchanged |
| 14 | PFX | Phenixfin CORP | -1% | -63.43% | Trim |
| 15 | RGNX | Regenxbio INC | -2.8% | -46.65% | Trim |
| 16 | ANEB | Anebulo Pharmaceuticals INC | — | EXIT | Sold out |
| 17 | FOXF | Fox Factory Holding CORP | — | NEW | New buy |
| 18 | MEC | Mayville Engineering Co INC | — | EXIT | Sold out |
| 19 | MGTX | MeiraGTx Holdings plc | — | EXIT | Sold out |
| 20 | SSKN | Strata Skin Sciences INC | — | EXIT | Sold out |
| 21 | PMDI | Psychemedics CORP | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-14 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-10 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-12 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-14 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-12 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-13 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-08 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-09 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-10 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001455139
Total reported value
$145.9M
148 stks
2017-09-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001513300
Total reported value
$145.9M
5 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002048608
Total reported value
$146.0M
75 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001010232
Total reported value
$272.4M
108 stks
2019-03-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Insperity INC
CIK 0001056807
Total reported value
$3.1B
41 stks
2026-03-31
1 of the top 5 holdings overlap, including Nektar Therapeutics
CIK 0001251567
Total reported value
$147.5M
9 stks
2026-03-31
1 of the top 5 holdings overlap, including Lifecore Biomedical INC